Skip to content
Search

Latest Stories

'Delta variant 60pc more transmissible than Alpha'

The Delta coronavirus variant of concern, first identified in India, is believed to be 60 per cent more transmissible than the Alpha variant which was previously dominant in Britain, a prominent UK epidemiologist said on Wednesday (June 9).

Neil Ferguson of Imperial College told reporters that estimates of Delta's transmission edge over Alpha had narrowed, and "we think 60 per cent is probably the best estimate".


Ferguson said that modelling suggested any third wave of infections could rival Britain's second wave in the winter - which was fuelled by the Alpha variant first identified in Kent, south east England.

But it was unclear how any spike in hospitalisations would translate into a rise in deaths, as more detail was needed on how well the vaccine protects against serious illness from Delta.

"It's well within possibility that we could see another third wave at least comparable in terms of hospitalisations," he said.

"I think deaths probably would be lower, the vaccines are having a highly protective effect... still it could be quite worrying. But there is a lot of uncertainty."

Britain has seen over 127,000 deaths within 28 days of a positive Covid-19 test, but has given more than three-quarters of adults a first dose of Covid-19 vaccine.

Public Health England has shown that the Delta variant reduces the effectiveness of Pfizer and AstraZeneca shots among those who have only received one shot, though protection is higher for those who have received both doses.

Ferguson said that up to a quarter of the Delta variant's transmissibility edge over Alpha might come from its immune escape from vaccines, saying it was "a contribution but not an overwhelming contribution" to its advantage.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less